Nuedexta and Ill-defined disorder - a phase IV clinical study of FDA data

Summary:

Ill-defined disorder is reported as a side effect among people who take Nuedexta (dextromethorphan hydrobromide; quinidine sulfate), especially for people who are female, 40-49 old, also take Ampyra, and have Multiple sclerosis.

The phase IV clinical study analyzes which people have Ill-defined disorder when taking Nuedexta. It is created by eHealthMe based on reports of 3,743 people who have side effects when taking Nuedexta from the FDA, and is updated regularly.

What is Nuedexta?

Nuedexta has active ingredients of dextromethorphan hydrobromide; quinidine sulfate. eHealthMe is studying from 3,781 Nuedexta users. Check the latest studies of Nuedexta.

What is Ill-defined disorder?

Ill-defined disorder is found to be associated with 1,464 drugs and 1,257 conditions by eHealthMe. Check the latest studies of Ill-defined disorder.



On Jul, 04, 2026

3,743 people reported to have side effects when taking Nuedexta.
Among them, 12 people (0.32%) have Ill-defined disorder.

Could Nuedexta cause Ill-defined disorder?

Among these 12 people:

What is the gender of people who have Ill-defined disorder when taking Nuedexta? *

  • female: 90.91 %
  • male: 9.09 %

What is the age of people who have Ill-defined disorder when taking Nuedexta? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 83.33 %
  • 50-59: 16.67 %
  • 60+: 0.0 %

What are other drugs people take besides Nuedexta? *

  1. Tysabri: 9 people, 75.00%
  2. Ampyra: 9 people, 75.00%
  3. Fluoxetine: 8 people, 66.67%
  4. Singulair: 6 people, 50.00%
  5. Neurontin: 5 people, 41.67%
  6. Cymbalta: 5 people, 41.67%
  7. Horizant: 5 people, 41.67%
  8. Hydrocodone Bitartrate And Acetaminophen: 5 people, 41.67%
  9. Mirapex: 5 people, 41.67%
  10. Ocrevus: 5 people, 41.67%

What are other side effects people have besides Ill-defined disorder? *

  1. Fatigue (feeling of tiredness): 9 people, 75.00%
  2. Pain: 8 people, 66.67%
  3. Mobility Decreased (ability to move is reduced): 8 people, 66.67%
  4. Fall: 7 people, 58.33%
  5. Multiple Sclerosis Relapse (reoccurrence of a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 6 people, 50.00%
  6. Balance Disorder: 5 people, 41.67%
  7. Depression: 5 people, 41.67%
  8. Gait Disturbance: 5 people, 41.67%
  9. Headache (pain in head): 5 people, 41.67%
  10. Migraine (headache): 5 people, 41.67%

What are the existing conditions these people have? *

  1. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 10 people, 83.33%
  2. Gait Disturbance: 5 people, 41.67%
  3. Stress And Anxiety: 1 person, 8.33%
  4. Sleep Disorder: 1 person, 8.33%
  5. Raynaud's Phenomenon (discoloration of the fingers, toes, and occasionally other areas): 1 person, 8.33%
  6. Primary Myelofibrosis (primary disorder of the bone marrow): 1 person, 8.33%
  7. Pain: 1 person, 8.33%
  8. Nausea (feeling of having an urge to vomit): 1 person, 8.33%
  9. Affect Lability (emotional incontinence): 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Nuedexta and have Ill-defined disorder?

- Check whether Ill-defined disorder is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, long term effects of, and alternative drugs to Nuedexta:

Ill-defined disorder treatments and more:

How severe was Ill-defined disorder and when was it recovered:

Expand to all the drugs that have ingredients of dextromethorphan hydrobromide; quinidine sulfate:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Nuedexta:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Ill-defined disorder:

Browse all the conditions that are associated with Ill-defined disorder:


How the study uses the data?

The study uses data from the FDA. It is based on dextromethorphan hydrobromide; quinidine sulfate (the active ingredients of Nuedexta) and Nuedexta (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: